MedTrace Logo

Photorefractive Intrastromal Corneal Crosslinking as a Treatment for Low Grade Myopia

NCT03987880 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2020-12-10

No results posted yet for this study

Summary

To assess the improvement in refractive error and the corneal endothelial safety with a customized corneal crosslinking treatment regimen for low grade myopia. The study compares two treatment protocols, a 4.0-mm central ring-shaped zone with a 3.5-mm central ring-shaped zone in high oxygen environment without corneal epithelial debridement.

Conditions

  • Myopia
  • Corneal Crosslinking
  • Refractive Errors
  • Eye Diseases

Interventions

PROCEDURE

4.0 mm treatment

PiXL treatment with UV irradiation in a central 4.0-mm ring-shaped zone of the cornea.

PROCEDURE

3.5 mm treatment

PiXL treatment with UV irradiation in a central 3.5-mm ring-shaped zone of the cornea.

Sponsors & Collaborators

  • Glaukos Corporation

    collaborator INDUSTRY

  • Umeå University

    lead OTHER

Principal Investigators

  • Anders Behndig, MD, PhD · Department of Clinical Sciences/Ophthalmology, Umeå University, Umeå, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-22
Primary Completion
2020-10-15
Completion
2020-10-15

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03987880 on ClinicalTrials.gov